Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

HIV JournalView: Top 10 HIV Clinical Developments of 2007

Drug Watch: Next Generation NNRTIs: Etravirine and Rilpivirine

HIV-Associated Pneumonias

Does tenofovir increase the risk of efavirenz-associated liver side-effects?

High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets.

Monitoring Board Finds HIV Combo Inferior

Estrogen May Protect Uncircumcised Men From HIV

Longer Treatment With Antiretroviral Nevirapine Reduces Risk of HIV Among Infants, Study Finds

Low rate of toxicity-related treatment change suggests HIV treatment tolerable in the long-term

Adherence predicts viral failure just as well as CD4 count change, South African study shows

Most viral load blips are short-lasting and of no significance

Experimental HIV Drug Hits Snag

Updated, Annotated Preventive Vaccine Pipeline Table